1. 2020
  2. Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33

    Romão, E., Krasniqi, A., Maes, L., Vandenbrande, C., Sterckx, Y. G-J., Stijlemans, B., Vincke, C., Devoogdt, N. & Muyldermans, S., 2 Jan 2020, In : International Journal of Molecular Sciences. 21, 1, 310.

    Research output: Contribution to journalArticleResearchpeer-review

  3. 2019
  4. Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors

    Bolli, E., D'Huyvetter, M., Murgaski, A., Berus, D., Stangé, G., Clappaert, E. J., Arnouk, S., Pombo Antunes, A. R., Krasniqi, A., Lahoutte, T., Gonçalves, A., Vuylsteke, M., Raes, G., Devoogdt, N., Movahedi, K. & Van Ginderachter, J. A., 28 Nov 2019, In : Journal of Controlled Release. 314, p. 1-11 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  5. 2018
  6. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20

    Krasniqi, A., Bialkowska, M., Xavier, C., Van der Jeught, K., Muyldermans, S., Devoogdt, N. & D'Huyvetter, M., 25 Oct 2018, In : New Biotechnology. 45, p. 69-79 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Same-day imaging using small proteins: Clinical experience and translational prospects in oncology

    Krasniqi, A., D'Huyvetter, M., Devoogdt, N., Frejd, F. Y., Sorensen, J., Keyaerts, M. & Tolmachev, V., Jun 2018, In : Journal of Nuclear Medicine. 59, 6, p. 885-891 7 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. Evaluation of [ 99mTc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice

    Bala, G., Baudhuin, H., Remory, I., Gillis, K., Debie, P., Krasniqi, A., Lahoutte, T., Raes, G., Devoogdt, N., Cosyns, B. & Hernot, S., 1 Apr 2018, In : Molecular Imaging and Biology. 20, 2, p. 260-267 8 p.

    Research output: Contribution to journalArticleResearchpeer-review

  9. 2017
  10. Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of Non-Hodgkin Lymphoma

    Krasniqi, A., D'Huyvetter, M., Xavier, C., Van der Jeught, K., Muyldermans, S., Van Der Heyden, J., Lahoutte, T., Tavernier, J. & Devoogdt, N., Dec 2017, In : Molecular Cancer Therapeutics. 16, 12, p. 2828-2839 12 p.

    Research output: Contribution to journalArticleResearchpeer-review

  11. Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)

    iHIVARNA consortium, Guardo, A. C., Tjok Joe, P., Miralles, L., Bargallo, M. E., Mothe, B., Krasniqi, A., Heirman, C., Garcia, F., Thielemans, K., Brander, C., Aerts, J. & Plana, M., 28 Jan 2017, In : AIDS. 31, 3, p. 321-332 12 p.

    Research output: Contribution to journalArticleResearchpeer-review

  12. 2016
  13. Theranostic radiolabeled anti-CD20 nanobody for targeted radionuclide therapy of Non-Hodgkin Lymphoma

    Krasniqi, A., Kahkelam Bungwa, M., Xavier, C., Van Der Jeught, K., Muyldermans, S., Lahoutte, T., Tavernier, J., D'Huyvetter, M. & Devoogdt, N., 10 Sep 2016.

    Research output: Unpublished contribution to conferenceUnpublished abstractResearch

  14. 131I-labeled anti-HER2 nanobody as a theranostic tool in cancer treatment

    D'Huyvetter, M., De Vos, J., Puttemans, J., Krasniqi, A., Xavier, C., Raes, G., Devoogdt, N., Zalutsky, M. & Lahoutte, T., 10 Sep 2016.

    Research output: Unpublished contribution to conferenceUnpublished abstractResearch

Previous 1 2 Next

ID: 166463